Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural Products.

Genes - 8 Apr 2024

Zhou Yalan, Peng Siqi, Wang Huizhen, Cai Xinyin, Wang Qingzhong

Abstract excerpt

In recent years, the FDA has approved numerous anti-cancer drugs that are mutation-based for clinical use. These drugs have improved the precision of treatment and reduced adverse effects and side effects. Personalized therapy is a prominent and hot topic of current medicine and also represents the future direction of development. With the continuous advancements in gene sequencing and high-throughput screening,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biological Products
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Pharmacogenetics

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 38674402
DOI: 10.3390/genes15040468
PMCID: PMC11049652

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural Products.PMID 38674402Read ↗

Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural ProductsSemantic proximity Read ↗

Personalized Medicine and CancerSemantic proximity Read ↗

Technological advances in clinical individualized medication for cancer therapy: from genes to whole organismSemantic proximity Read ↗

The Precision Medicine: Advancement and Transformation in Cancer TreatmentSemantic proximity Read ↗

Precision Oncology: Targeting Genomic Alterations and Cancer Signaling with Integrative Multi-Omics, Deep Learning and Network Biology in Medical OncologySemantic proximity Read ↗

Molecular Target and Action Mechanism of Anti-Cancer AgentsSemantic proximity Read ↗

Integrative omics analyses broaden treatment targets in human cancer.Semantic proximity Read ↗

The Precision Oncology Approach to Molecular Cancer Therapeutics Targeting Oncogenic Signalling Pathways Is a Means to an EndSemantic proximity Read ↗

DBPOM: a comprehensive database of pharmaco-omics for cancer precision medicineSemantic proximity Read ↗

Pharmacogenomics in Practice: Why Traditional Medicine Still LeadsSemantic proximity Read ↗

A comprehensive map of molecular drug targets.Semantic proximity Read ↗

Identification of Genetic Mutations in Cancer: Challenge and Opportunity in the New Era of Targeted TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.